论文部分内容阅读
Aim: The platelet responses to antiplatelet drugs are highly variable.However,the associated mechanisms are poorly defined.The present study aimed to investigate PEAR1 genetic polymorphisms and pharmacogenetic variability in the pharmacodynamics of prasugrel, a new oral antiplatelet agent, in 36 healthy Han Chinese subjects.